On April 29, 2025, the makers of the Eversense 365-day implantable continuous glucose monitor announced a partnership with Sequel MedTech.
Sequel MedTech is the maker of the Twiist AID (automated insulin delivery) system.
The Eversense CGM is developed by Senseonics Medical Technology and brought to market by Ascensia Diabetes Care. This partnership with the TWiist pump creates new diabetes management options for people using AID systems.
Learn more about Eversense in this video: https://www.youtube.com/watch?v=kv5B7pnTgpE&feature=youtu.be
Ginger Vieira has lived with type 1 diabetes since 1999 along with a few other chronic illnesses! She is the Cofounder of the Diabetes Nerd Network and the Diabetes Nerd Marketing agency. Ginger has authored hundreds of articles and several books, including Exercise with Type 1 Diabetes, Pregnancy with Type 1 Diabetes, Dealing with Diabetes Burnout, and Stop Overeating During Lows. Over her 20-year career (so far) in diabetes, she’s produced hundreds of articles and videos about life with diabetes. Her background includes a Bachelor of Science in professional writing and certifications in coaching, personal training, powerlifting, and Ashtanga yoga.